ГоловнаArchive of numbers2017Volume 25, issue 2 (91)Optimization of approaches to the treatment of depressive disorders
Title of the article Optimization of approaches to the treatment of depressive disorders
Authors Fedchenko Viktoriya
In the section DIAGNOSTICS AND THERAPY OF MENTAL AND NARCOLOGICAL DISORDERS
Year 2017 Issue Volume 25, issue 2 (91) Pages 76-79
Type of article Scientific article Index UDK 616.895.4-08 Index BBK -
Abstract The article presents the materials on the increase of effi ciency of treatment of depressive disorders based on the study of early biomarkers of response to antidepressants, which were presented at the 29th Congress of the European College of Neuropsychopharmacology in Vienna (Austria) 17—20 September 2016.
Key words depressive disorders, antidepressants, early biomarkers of response to therapy
Access to full text version of the article pdf download
Bibliography 1. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline / [Demyttenaere K., Corruble E., Hale A., et al.] // CNS Spectr. 2013; 18(3): 163—170.
2. Kasper S., Hajak G. The efficacy of agomelatine in previouslytreated depressed patients // Eur Neuropsychopharmacol. 2013; 23(8): 814—821.
3. Ketamine: stimulating antidepressant treatment? / [Malhi G. S., Byrow Y., Cassidy F., et al.] // Br J Psych Open. 2016. 2, e5-e9. DOI: 10.1192/bjpo. bp.116.002923.
4. Stahl S. M. Classifying psychotropic drugs by mode of action and not by target disorder // CNS Spectr. 2013; 18(3): 113—117.
5. Serotonergic drugs for depression and beyond / [Stahl S. M., Lee-Zimmerman C., Cartwright S., Morrissette D. A.] // Curr Drug Targets. 2013: 14(5): 578—585.
6. Kasper S., Hajak G. The efficacy of agomelatine in previouslytreated depressed patients // Eur Neuropsychopharmacol. 2013; 23(8): 814—821.
7. Stein D. J., Picarel-Blanchot F., Kennedy S. H. Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression // Hum Psychopharmacol. 2013; 28(2): 151—159.
8. Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies / [Taylor D., Sparshatt A., Varma S., Olofinjana O.] // BMJ. 2014; 348. DOI: 10.1136/bmg.g1888.
9. Harmer C. J., Goodwin G. M., Cowen P. J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009; 195(2): 102—108.
10. Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients / [Harmer C. J., O'Sullivan U., Favaron E. et al.] // Am J Psychiatry. 2009; 166(10): 1178—1184. DOI: 10.1176/appi.ajp.2009.09020149.
11. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients / [Tranter R., Bell D., Gutting P., et al.] // J Affect Disord. 2009; 118(1—3):87—93. DOI: 10.1016/j.jad.2009.01.028. Epub 2009 Feb 27.
12. Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression / [Shiroma P. R., Thuras P., Johns B., Lim K. O.] // Int J Geriatr Psychiatry. 2014; 29(11):1132—1139.
13. Neurobiology of emotion perception II: Implications for major psychiatric disorders / [Phillips M. L., Drevets W. C., Rauch S. L., Lane R.] // Biol Psychiatry. 2003; 54(5): 515—528.
14. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial / [Brunoni A. R., Valiengo L., Baccaro A. et al.] // JAMA Psychiatry. 2013; 70(4): 383—391.
15. Frontal Cortex Stimulation Reduces Vigilance to Threat: Implications for the Treatment of Depression and Anxiety / [Ironside M., O'Shea J., Cowen P. J., Harmer C. J.] // Biol Psychiatry. 2016; 15; 79(10): 823—830.
16. Oxford study aims to find anti-depressants that work faster for patients : http://www.ox.ac.uk/news/2016-05-20-oxford-studyaims- find-anti-depressants-work-faster-patients